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Abstract
The human Ab peptide causes progressive paralysis when expressed in the muscles of the nematode worm, C. elegans. We
have exploited this model of Ab toxicity by carrying out an RNAi screen to identify genes whose reduced expression
modifies the severity of this locomotor phenotype. Our initial finding was that none of the human orthologues of these
worm genes is identical with the genome-wide significant GWAS genes reported to date (the ‘‘white zone’’); moreover there
was no identity between worm screen hits and the longer list of GWAS genes which included those with borderline levels of
significance (the ‘‘grey zone’’). This indicates that Ab toxicity should not be considered as equivalent to sporadic AD. To
increase the sensitivity of our analysis, we then considered the physical interactors (+1 interactome) of the products of the
genes in both the worm and the white+grey zone lists. When we consider these worm and GWAS gene lists we find that 4
of the 60 worm genes have a +1 interactome overlap that is larger than expected by chance. Two of these genes form a
chaperonin complex, the third is closely associated with this complex and the fourth gene codes for actin, the major
substrate of the same chaperonin.
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Background
Once age is taken into account, the most powerful determinants
of risk for Alzheimer’s disease (AD) are genetic; indeed, the
heritability of the disorder is estimated to be 58–79% [2,3]. In the
clinic however, this strong genetic influence is not readily apparent
because of the heterogeneous, multigenic inheritance of so-called
sporadic AD. Such complexity has encouraged geneticists to focus
on a small minority of AD cases that exhibit dominant Mendelian
inheritance [4,5]. Remarkably, these studies have shown that the
bulk of the genetic lesions resulting in familial AD (FAD) directly
influence the proteolytic processing of a single transmembrane
protein called amyloid precursor protein (APP) [6]. The cleavage
of APP by b-secretase and then c-secretase results in the
generation of a spectrum of peptides, known as amyloid b (Ab),
that are the major component of senile plaques in the brains of
patients with AD. The c-secretase is of particular interest because
its cleavage of APP determines which amino acids constitute the
C-terminus of Ab. Normally, Ab peptides are predominantly 40
amino acids in length (Ab40), while 5–10% have a further 2 amino
acids at the C-terminus (Ab42). The bulk of cases of FAD can be
accounted for by mutations that either increase the total amount of
Ab [7,8], or favour the production of longer, more aggregation-
prone, isoforms of the peptide [9]. FAD has been reported to be a
consequence of variation in the sequence or copy number of either
the APP gene, or the genes PSEN1 or PSEN2 encoding catalytic
subunits of c-secretase [7,8]. Likewise, protection from AD has
also been linked to a polymorphism in APP that interferes with b-
secretase cleavage [10]. These data, supported by studies on
sporadic AD patients [11], have given rise to the amyloid cascade
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hypothesis that places the aggregation of Ab as the first step on the
road to AD [6].
The advent of genome-wide association studies (GWAS) has
made the investigation of multigenic disorders, such as sporadic
AD, experimentally tractable. Using p,1027 as an empirical cut
off for genome-wide significance (the GWAS ‘‘white zone’’), the
first generation of multicentre AD GWAS [12,13] reported four
genes (apoE, clusterin, PICALM, and CR1) associated with disease
risk. With the publication of the second generation of GWAS
findings, the total number of risk genes is now twenty one [1,14].
Notable absentees from these lists are any of the genes implicated
in FAD. These findings may lead us to question the relevance of
Ab in the pathogenesis of sporadic AD and might indicate that the
sporadic and familial forms are different diseases.
One explanation for the absence of genes such as APP, PSEN1,
or PSEN2 from the list of candidates identified by GWAS is that
the studies were lacking sufficient power to detect small or rare
contributions to risk [15]. Increased power could be achieved by
recruiting more patients and controls and by increasing the density
of SNP genotyping [15]. However, we have taken a parallel
approach by including in our analysis not only the genes with
genome-wide significance (GWAS ‘‘white zone’’), but also GWAS
results of borderline significance (GWAS ‘‘grey zone’’) with p-
values between ,1025. This larger list of genes will include false
positives, that can safely be ignored, but equally there will be genes
that carry risk and are involved in the pathogenesis of sporadic
AD. Our approach has been to probe this larger group of GWAS
white+grey zone genes using the results of a genome-scale screen
in a model system that reports exclusively on the toxicity of the Ab
peptide. We postulate that if Ab toxicity were distinct from
sporadic AD then we would expect to see an overlap between the
worm and human genes lists that is consistent with chance.
However were the GWAS data reporting a role for Ab in clinical
AD we would expect to see a significantly increased overlap in the
network of genes identified in the human and worm screens.
Results
Feeding RNAi to C. elegans modifies the Ab-induced
paralysis phenotype
We identified 7970 human protein-encoding genes that have
orthologues in C.elegans and we used a subset of the Ahringer C.
elegans RNAi library [16] to systematically knock down the
transcript levels of each of these genes. The phenotypic
consequences of each genetic knock-down were assessed in worms
following the induction of Ab expression under the control of a
heat-inducible myocyte-specific promoter. The optimal age for Ab
induction was 48 h (stage L3) because this resulted in 50%
paralysis 30 h later (Fig. S1). Induction of Ab expression in
younger worms resulted in a more rapid progression of paralysis.
Rigorous primary and secondary screens identified RNAi clones
that significantly (p,0.05, n= 12 with 4 biological replicates)
enhanced or suppressed the Ab-induced paralysis phenotype.
Clones that modified paralysis were positively identified by DNA
sequencing. In this way, we identified 78 worm genes that
significantly suppressed (Table 1) the Ab-induced paralysis phe-
notype. Of the 3 genes that significantly enhanced the phenotype
none has a human orthologue (Table 2).
Human orthologues of worm screen hits are not identical
to GWAS genes but are network hubs
In our initial analysis, we generated a list of the human
orthologues of the worm modifier genes using EnsemblCompara
[17], and found that 61 out of the 78 worm genes had human
counterparts. This ratio is significantly higher than one would
expect by chance if one considers that there are only 7,970 worm
genes that have human orthologues out of a genome of
approximately 20,000 genes [18]. The p-value for this enrichment
is p,10211 (binomial test using probability of success = 7970/
20000, number of successes = 61, number of trials = 78), indicating
that the hits in the worm screen are much more likely to have
human orthologues than one would expect by chance.
Using worm ontology enrichment analysis (clueGO plugin for
Cytoscape) we found that a number of labels were over-
represented in our screen hits, implicating genes involved in
ATP synthesis, purine metabolism, protein binding and chaperone
activity, and components of the translational machinery (Table 3).
When we compared this list of 61 human orthologues of the
worm modifier genes with the 63 genes in the GWAS white+grey
zone (Table S1) we found no identity between the two gene lists.
Indeed when we compared the ontology labels associated with the
GWAS genes and the human orthologues of worm screen hits we
found that there was no significant similarity (using WEB-based
GEne SeT AnaLysis Toolkit, bioinfo.vanderbilt.edu/webgestalt/).
However using the BioGrid database (v. 3.2.96) [19] we found that
6 of the human orthologues of worm screen genes coded for
proteins that interact directly with the products of the GWAS
white+grey zone genes.
In order to determine which, if any, of the worm screen hits
interacted with the GWAS list to a statistically significant degree
we supplemented the candidate gene lists with genes encoding the
first-degree physical interactors (+1 interactome) of the protein
products of the primary members using the BioGrid database (v.
3.2.96). We then asked, for each member of the worm-screen hit
list, whether their +1 interactome overlap with GWAS was
greater, or less, that one would expect by chance (Fig. S2). Of the
61 worm genes, 60 were present in the Biogrid database and we
considered these further in our analysis. Of the 63 genes in the
GWAS white+grey zone, 52 were present in Biogrid database.
It was immediately apparent from the relative sizes of the +1
interactomes (Figs. 1 & 2) that the genes derived from the worm
screen were more highly interacting than the GWAS list.
Specifically each worm screen gene orthologue had, on average,
53 interactors as compared to the GWAS list where the value was
less than 14.
Ranking the distribution of gene interconnectivity
In order to determine whether the observed bias towards highly
interconnected genes in the worm modifier list was statistically
significant, we used a computational approach to compare our
observed population of genes to similar, randomly generated, lists.
Firstly we ranked the population of human genes in the Biogrid
database (13940 genes) according to their number of interactors.
This ranked list was then divided into 10 bins such that each bin
contained the same number of human orthologues of worm genes
(that is 797 in each bin). For example, this resulted in the most
highly interconnected 952 human genes in the database being put
into the first bin; the bin boundaries for the whole database were:
1–952, 953–2006, 2007–3175, 3176–4403, 4404–5735, 5736–
7134, 7135–8624, 8624–10200, 10201–12104 and 12105–13928.
Using a Monte-Carlo approach [20] we then generated 100 lists
containing 60 randomly generated human genes with worm
orthologues.
As expected the genes in the random lists segregated with equal
frequency into the various bins (Fig. 3, triangles); however, a
consequence of the highly interconnected nature of the worm
screen gene list is that .50% of its members (31 out of 60) fall
within the most highly interconnected bin on the left side of graph.
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Table 1. Suppressors of the Ab-paralysis phenotype.
C. elegans gene
symbol Human gene name
Human gene
symbol Accession number
F46E10.1 Long chain fatty acid acyl-CoA ligase ACSF2 NM_001028767
T04C12.6 Actin and related proteins ACTB NM_073416
T25C8.2 Actin and related proteins ACTG1 NM_067408
K07C5.1 Actin-related protein Arp2/3 complex, subunit Arp2 ACTR2 NM_073256
F55A12.7 AP-1 complex subunit mu-1 AP1M1 NM_059171
F29G9.3 Clathrin adaptor complex, small subunit AP1S2 NM_072158
C13B9.3 Medium subunit of clathrin adaptor complex ARCN1 NM_066062
C34E10.6 F0F1-type ATP synthase, beta subunit ATP5B NM_065710
R10E11.8 Vacuolar H+-ATPase V0 sector, subunits c/c’ ATP6V0C NM_066764
Y49A3A.2 Vacuolar H+-ATPase V1 sector, subunit A ATP6V1A NM_074158
F20B6.2 Vacuolar H+-ATPase V1 sector, subunit B ATP6V1B2 NM_076310
Y55F3AR.3 Chaperonin complex component, TCP-1 theta subunit (CCT8) CCT8 NM_067634
F09G2.4 mRNA cleavage and polyadenylation factor II complex, subunit CFT2 (CPSF subunit) CPSF2 NM_072421
M03F8.3 Cell cycle control protein (crooked neck) CRNKL1 NM_001129507
B0464.1 Aspartyl-tRNA synthetase DARS NM_066688
C55B6.2 dsRNA-activated protein kinase inhibitor P58, contains TPR and DnaJ domains DNAJC3 NM_076808
D2085.3 Translation initiation factor 2B, epsilon subunit (eIF-2Bepsilon/GCD6) EIF2B5 NM_063440
F22B5.2 Translation initiation factor 3, subunit g (eIF-3g) EIF3G NM_001276737
C40H1.4 Elongation of very long chain fatty acids protein 3 ELOVL3 NM_066655
H19N07.1 Eukaryotic Peptide Chain Release Factor GSPT2 NM_001269363
T10C6.11 Histone H2B HIST1H2BA NM_074630
F26D10.3 Molecular chaperones HSP70/HSC70, HSP70 superfamily HSPA8 NM_070667
C49F5.1 S-adenosylmethionine synthetase MAT1A NM_077601
C30A5.3 MOB-Like Protein Phocein MOB4 NM_066397
Y57G11C.12 NADH:ubiquinone oxidoreductase, NDUFA6/B14 subunit NDUFA6 NM_070389
K07C5.4 Ribosome biogenesis protein - Nop56p/Sik1p NOP56 NM_073259
T22B11.5 2-oxoglutarate dehydrogenase, E1 subunit OGDHL NM_068216
D1054.15 Isoform 1 of Pleiotropic regulator 1 PLRG1 NM_001269330
F36A4.7 RNA polymerase II, large subunit POLR2A NM_068122
K02B12.3 Prolactin regulatory element binding PREB NM_059904
R07E4.6 CAMP-dependent protein kinase type I-Alpha, regulatory subunit PRKAR1A NM_076598
C50C3.6 U5 snRNP spliceosome subunit PRPF8 NM_066384
CD4.6 20S proteasome, regulatory subunit alpha type PSMA1/PRE5 PSMA1 NM_072071
Y38A8.2 20S proteasome, regulatory subunit beta type PSMB3/PUP3 PSMB3 NM_062512
C52E4.4 26S proteasome regulatory complex, ATPase RPT1 PSMC2 NM_073604
Y49E10.1 26S proteasome regulatory complex, ATPase RPT6 PSMC5 NM_067208
C23G10.4 26S proteasome regulatory complex, subunit RPN2/PSMD1 PSMD1 NM_065946
C39F7.4 GTPase Rab1/YPT1, small G protein superfamily, and related GTP-binding proteins RAB1A NM_070996
F10B5.1 60s ribosomal protein L10 RPL10L NM_063306
T22F3.4 60S ribosomal protein L11 RPL11 NM_071607
C27A2.2 60S ribosomal protein L22 RPL22 NM_062531
C09H10.2 60S ribosomal protein L44 RPL36AL NM_063974
B0250.1 60s ribosomal protein L2/L8 RPL8 NM_075539
R13A5.8 60S ribosomal protein L9 RPL9 NM_066259
F54E7.2 40S ribosomal protein S12 RPS12 NM_065820
C16A3.9 40S ribosomal protein S13 RPS13 NM_065992
T01C3.6 40S ribosomal protein S16 RPS16 NM_074289
T05F1.3 40S ribosomal protein S19 RPS19 NM_060154
C23G10.3 40S ribosomal protein S3 RPS3 NM_065948
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More generally, the worm screen gene list exhibited a power law
distribution such that we could fit a linear regression line (gradient
21.1) to a log-log plot of gene rank bin boundary vs. frequency of
observation (Fig. 3, diamonds).
To determine whether the bias is statistically significant we
performed a two-tailed Student’s t-test [21] to see whether the
gradient of the experimental regression line is different from the
data generated in the Monte Carlo simulations. A p-value of 0.004
indicates that indeed the hits from our worm screen are more
highly interconnected that a comparable random population.
To understand whether such a bias is a common feature of
worm RNAi screens, we repeated a similar analysis for three
published modifier screens of human neurodegenerative disorders
(modelling polyglutamine [22] [Table S2a], tau [23] Table S2b]
and alpha-synuclein pathogenesis [24] [Table S2c]) and, congru-
ent with our results, we also found a skew in these screens towards
highly interconnected genes (Fig. 4 A–C). Using a one-tailed
Table 1. Cont.
C. elegans gene
symbol Human gene name
Human gene
symbol Accession number
B0393.1 40S ribosomal protein SA (P40)/Laminin receptor 1 RPSA NM_065577
F53E10.6 RRP15-like protein RRP15 NM_071312
VZK822L.1 Fatty acid desaturase SCD NM_001268666
F43D9.3 Sec1 family domain-containing protein 1 SCFD1 NM_001129225
Y113G7A.3 Vesicle coat complex COPII, subunit SEC23 SEC23B NM_075476
Y57E12AL.1 Tumor differentially expressed (TDE) protein SERINC1 NM_171479
T08A11.2 Splicing factor 3b, subunit 1 SF3B1 NM_065452
Y116A8C.42 Small nuclear ribonucleoprotein Sm D3 SNRPD3 NM_070626
ZK652.1 Small Nuclear Ribonucleoprotein Polypeptide F SNRPF NM_066307
T27F2.1 SNW domain-containing protein 1 SNW1 NM_073549
F55A11.2 SNARE protein SED5/Syntaxin 5 STX5 NM_073567
T05C12.7 Chaperonin complex component, TCP-1 alpha subunit (CCT1) TCP1 NM_063321
Y116A8C.35 U2 small nuclear RNA auxillary factor 1 isoform b U2AF1 NM_070635
C47E12.5 Ubiquitin-like modifier activating enzyme 6 UBA6 NM_001268520
*C46G7.1 – – NM_068504
*F28C6.7a – – NM_063422
*Y105E8C.e – – N/A
*K04E7.2 – – NM_076686
*F58G6.7 – – NM_069313
*ZK858.1 – – NM_060045
*Y41D4B.19 – – NM_067703
*F42D1.3 – – NM_078054
*F55C5.4 – – NM_073679
*F17C8.5 – – NM_065572
*C41C4.7a – – NM_063303
*W09B6.1 – – NM_001267098
*D2024.1 – – NM_068750
*W06H8.8 – – NM_001029030
*F25B5.4 – – NM_171139
The list consists of the human orthologues of worm genes that, when targeted by RNAi, suppress the paralysis phenotype in Ab-expressing worms (n = 78 genes).
doi:10.1371/journal.pone.0102985.t001
Table 2. Enhancers of the Ab-paralysis phenotype.
C. elegans gene symbol Human gene name Human gene symbol Accession number
W02B8.3 – – NM_064514
F08E10.7 – – NM_075028
F35A5.3 – – NM_076258
The list consists of the human orthologues of worm genes that, when targeted by RNAi, enhance the paralysis phenotype in Ab-expressing worms (n = 3 genes).
doi:10.1371/journal.pone.0102985.t002
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Student’s t-test we observed that for the polyQ (p= 0.0002, Fig. 4,
panel A), the a-synuclein (p = 0.04, panel B), and the tau (p = 0.04,
panel C) screens, the gradient of the linear regression lines was
significantly less than for the Monte-Carlo-generated data. By
contrast the equivalent gradient of the GWAS white+grey zone
genes was robustly zero (p = 0.22, two-tailed, panel D).
The bias toward highly interacting networks in the results of a
number of worm modifier screens, including our own, precludes
any simple analysis of the overlap between the worm screen and
GWAS +1 interactomes. This is because some of the worm genes
have several hundred interactors and are likely to generate an
overlap by chance. For example HSPA8 constitutes over 30% of
the overlap using the hits from our Ab screen. For these reasons,
we developed a more robust method for determining whether the
overlap in the worm and GWAS interactomes was significant or
not.
Determining the statistical significance of the overlap
between worm screen hits and GWAS results
To compensate for the bias towards highly interacting genes in
the worm screen, we designed random Monte Carlo simulations in
which each simulated worm +1 interactome has the same size as
the particular worm screen gene product being tested.
The statistical significance (p-value) of the overlap between the +
1 interactome of each worm screen hit and the GWAS +1
interactome was achieved by generating 1000 random worm +1
interactomes of equivalent size for each experimental worm gene.
We then counted how often the overlap of the random worm +1
interactomes with the GWAS +1 interactome was either.=or,
= to the experimentally observed overlap. To quantify the
statistical significance of our findings, we repeated this process
for 100 random lists of 60 worm genes.
Overall, we found that, of the 100 random lists of 60 worm
genes, 3.14 (95% confidence interval =60.34) genes had +1
interactome overlaps with GWAS that differed significantly from
expected at a level of p,0.05. As such, this number is consistent
with the random nature of the simulated gene lists. However when
we examined the experimental worm screen list, we found that 7
genes had a non-random +1 interactome overlap with the GWAS
network. When we reviewed our simulations we found that out of
100 runs only 5 resulted in 7 or more genes that had a +1
interactome overlap that differed from chance, yielding p= 0.05
for our observation.
Genes with non-random +1 interactome overlaps
When we considered the overlap between the 7 non-random
worm genes we found that 3 (NOP56, PSMA1 and RPL10L; Fig.
S5) had a lower +1 interactome overlap with the GWAS list than
would be expected by chance. The remaining four worm genes are
of particular interest because they have a larger +1 interactome
overlap with GWAS than expected. Remarkably, two of these
genes (TCP1, CCT8) are components of the TRiC/CCT
chaperone complex and the third (MOB4) interacts closely
[25,26]. The fourth gene is one of the major folding substrates
of the chaperone, namely actin (ACTB). Furthermore, TCP1,
CCT8 and MOB4 all interact directly with a single GWAS grey
zone gene, namely the kinase STK24 [26] (Fig. 5).
Discussion
Genome-wide association studies [1,13,14] and a subsequent
targeted genotyping screen [15] have shown that none of the genes
implicated in FAD carry common variants that confer risk for the
sporadic version of the disease. These results have called into
question the validity of using familial AD, where the pathogenesis
is undoubtedly related to Ab generation, as a model for the more
common sporadic AD. In particular, it is possible that the sporadic
disease may have a distinct pathogenesis, perhaps based on
immune dysregulation, that is not based on aberrant APP
metabolism and the consequent production of Ab. To address
this issue, we have employed an invertebrate model system that
exclusively reports the toxicity of Ab; that is, a worm expressing
Ab under the control of a muscle-specific driver. While, in this
particular model system, the paralysis is likely to be caused by
muscle damage, rather than neurodegeneration, it is known that
Ab toxicity can be observed across a wide range of cell types and
the mechanisms may well be conserved.
The worm screen in this study has reported on worm gene
transcripts that, when targeted by RNAi, modify the Ab-induced
paralysis phenotype. The deployment of rol-6 as a marker of Ab
expression means that we can rule out any marked artefactual loss
of the expression array in response to RNAi. However, we did not
measure expression levels of the Ab peptide in response to each
RNAi treatment, so we cannot exclude the possibility that for a
particular RNAi treatment that effects on paralysis could be
attributed to changes in transgene expression rather than an effect
on Ab toxicity. Furthermore this study can usefully be extended by
including worm lines carrying mutant alleles of the genes
implicated by the RNAi studies both in mammalian systems and
in C. elegans.
In this study our goal was to use the results of the worm genetic
screen to detect GWAS genes with borderline significance that
were nevertheless involved in the pathogenesis of sporadic AD.
Our initial, and most stringent, test indicated that none of the
genes in the GWAS white or grey zones were identical to the
human orthologues of the 61 worm modifier genes. This negative
finding suggests that, at least for the predominantly Caucasian
populations in which GWAS studies have been performed, Ab
toxicity cannot be considered as identical to sporadic AD. Rather
the data support the idea that other pathological pathways may be
important in the disorder. However, we did observe that 6 worm
gene orthologues were predicted to interact physically with
members of the GWAS white+grey zone gene products (Table 4,
asterisks). It was also notable that worm modifier genes were much
more likely than chance to have a human orthologue. This
involvement of a core and essential and highly conserved genes
reflects the profound toxic effect posed by Ab.
Table 3. Gene ontology enrichment for worm screen hits.
Molecular function
Proton transporting ATP synthase activity, rotational mechanism
Proton transporting ATPase activity, rotational mechanism
Cellular component
Cytosolic small ribosomal subunit
Eukaryotic translation initiation factor 3 complex
Chaperonin-containing T-complex
Biological process
Protein binding
Structural constituent of ribosome
Purine nucleotide binding
The worm screen hits were analysed for enrichment in molecular function,
cellular component and biological process ontology labels.
doi:10.1371/journal.pone.0102985.t003
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In order to determine whether the degree of interaction
between the worm and GWAS genes was greater, or less, than
one would expect by chance we systematically compared the
overlap between the worm and GWAS +1 interactomes for each
of the worm-screen genes (Fig. S2).
Worm-screen hits, but not the GWAS list, are highly
interconnected genes
Considering the +1 interactomes of the worm genes from our
Ab-based screen, we observed that there was a clear bias toward
genes encoding highly interactive proteins. As can be seen from
Fig. 3, there is a power law relationship between the frequency
with which we observe particular gene products and their
particular degree of interconnectedness. For our screen, the
gradient of the linear fit of the log-log plot is 21.1. This is
significantly different from a gradient of zero, which we observed
for a random set of genes where the chance of observing a gene is
independent of its degree of interconnectivity.
We were interested to know whether the gene lists from other
genetic screens in worm models of human disease also generated
similarly skewed distributions of connectivity. Indeed, when we
analysed the data for polyQ, synuclein and tau screens, we found
that they all had a negative slope (21.4, 20.5, and –0.4,
respectively) and all were significantly different from the expected
zero value.
One possible explanation for the highly interconnected nature
of the worm screen hits could be summarised as ‘‘sociological bias’’
[27]. In this context, we hypothesise that previous worm screens
have yielded similar gene lists and that the consequent interest in
the field has resulted in more interaction data being deposited in
the BioGrid database. In support of this hypothesis, we find that
the screens for Ab and polyQ yield 27 common genes, and we find
that 20 of them are highly interconnected genes (present in the first
Figure 1. GWAS genes +1 interactome. The +1 interaction network for the 52 GWAS genes with intermediate and high significance (p,105). For
the 52 genes in the GWAS white+grey zones, there were 703 interactions in the +1 interactome.
doi:10.1371/journal.pone.0102985.g001
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bin in plots in Figs. 3 & 4). Even if there is such a sociological bias,
this does not invalidate subsequent conclusion because we have
carefully compensated for differences in network connectivity.
Another explanation is that genetic modifiers of worm
phenotypes really do have more highly interconnected protein
products as compared to the average gene [28]. Highly
interconnected gene products are likely involved in more
biological pathways than less connected ones; so it may be that
highly interconnected gene products are more likely to influence
disease-related processes as assessed by a genetic screen. However
this cannot explain why there is no similar interconnectivity bias
when the same analysis is applied to the GWAS white+grey zone
genes. Indeed, the distribution of connectivity of the products of
white+grey zone genes is remarkably similar to that of the general
population of genes. This is likely to be explained by the presence
of many false-positive genes in this list.
Figure 2. Worm genes +1 interactome. The +1 interaction network for the human orthologues of the 60 worm genes that were highlighted in
our worm RNAi screen. For the 60 worm-screen genes with human orthologues, there were 3191 interactions in the +1 interactome.
doi:10.1371/journal.pone.0102985.g002
Figure 3. Distribution of rankings of worm genes. The x-axis
represents the log of the gene ranking bin boundaries, arranged in
decreasing gene-product connectedness from left to right. The y-axis
represents the log of the fraction of genes in each bin (where 100% is
60 genes). The dashed line shows the linear regression for the worm
screen results. The results of the screens are shown as black diamonds
and results of random simulations are shown as empty triangles.
doi:10.1371/journal.pone.0102985.g003
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Worm-GWAS overlap analysis implicates the TRiC/CCT
chaperone in mediating Ab toxicity in sporadic
Alzheimer’s disease
For each gene in the worm-screen hit list we estimated whether
its interactome overlapped with the GWAS interactome to a
greater or lesser extent than would be expected by chance. We
employed a Monte Carlo simulation approach where we
generated 1000 random interactomes that were the same size as
the experimental interactome (Fig. S3) and determined the
distribution of the overlap scores (Fig. S4). For 7 of the 60 worm
genes we found that the overlap differed significantly from the
chance expectation.
Three of these genes (NOP56, PSMA1 and RPL10L) have +1
interactome overlaps with GWAS white+grey zone genes that are
smaller than one would expect by chance, suggesting that they are
artifactual modifiers of the worm phenotype and unlikely to be
involved in the human disorder. Consequently, these data should
dissuade us from investigating the ribosomal [29] and proteasomal
[30] functions of these genes in AD. By contrast, the remaining 4
genes exhibited a greater than expected +1 interactome overlap
with the GWAS white+grey zone genes. Furthermore, we found
that two of these genes (TCP1, CCT8) are both members of the
TRiC/CCT chaperone that has a number of substrates including
actin (ACTB is the fourth gene) and tubulin. This chaperone
complex was also enriched in the gene ontology analysis of the
worm hits (Table 3). CCT8 and MOB4 have not been observed as
modifiers in any other worm models of neurodegeneration
however TCP1 and ACTB RNAi also modify polyQ toxicity
[22,23,24]. While this may represent conservation of pathological
mechanisms between Ab and polyQ it may alternatively indicate
that TCP1 and ACTB RNAi constructs have non-specific effects
in worm model systems. It is notable that TCP1 levels are
abnormal in foetal Down’s syndrome [31]. Furthermore TCP1,
CCT8 and MOB4 all interact with each other and also with the
kinase STK24, a member of the GWAS grey zone, that has been
linked to axonal regeneration in rats [32]. These three candidate
genes, along with STK24 and PP2A, form a multiprotein complex
that may regulate the MAPK pathway [33]. From our analysis, we
propose that both neuroregenerative pathways linked to STK24
and also the MAPK-linked phosphorylation of proteins such as tau
[34] may be the mechanisms by which the TRiC/CCT chaperone
exerts its effects in AD.
Figure 4. Distribution of rankings of worm models of neurodegenerative diseases. The x-axis represents the log of the gene ranking bin
boundaries, arranged in decreasing gene-product connectedness from left to right. The y-axis represents the log of the fraction of genes in each bin
(where 100% is 135, 23, 22 & 52 genes for panels A, B, C & D respectively). The dashed line shows the linear regression for the worm screen results.
The results of the screens are shown as black diamonds and results of random simulations are shown as empty triangles. (A) polyglutamine screen; (B)
a-synuclein screen; (C) tau screen; (D) GWAS candidate white+grey zone genes for AD.
doi:10.1371/journal.pone.0102985.g004
Figure 5. The interaction network of 4 significant worm gene
products. Four human orthologues of worm screen gene products
(MOB4, TCP1, CCT8 and ACTB) have +1 interactomes that overlap more
than expected with the +1 interactome of the GWAS white+grey gene
products. Two of these are components of the abundant cytoplasmic
TRiC/CCT chaperone, the third (MOB4) interacts closely and fourth
(ACTB), along with tubulin, is an important substrate. TRiC/CCT interacts
with STK24 and PP2a to form a complex that regulates the MAPK
pathway. This network of interactions may have a bearing on tau
phosphorylation and neuronal regeneration.
doi:10.1371/journal.pone.0102985.g005
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Table 4. Overlap between the +1 interactome for the products of genes in the GWAS white+grey zone and those of genes in
the +1 interactome of the worm RNAi screen.
Gene p-value +1 interactome overlap [experimental vs MC]
MOB4 0.003 larger*
PSMA1 0.014 smaller
TCP1 0.014 larger*
NOP56 0.014 smaller
CCT8 0.015 larger*
ACTB 0.018 larger
RPL10L 0.033 smaller
RPL9 0.058 smaller
ATP6V1B2 0.064 smaller
HSPA8 0.065 larger
RPL22 0.087 smaller
PSMB3 0.089 smaller
RPL11 0.097 smaller
RPS13 0.12 smaller
PSMC2 0.131 smaller
PSMD1 0.137 smaller
PRPF8 0.141 smaller*
ACTR2 0.153 larger
ACTG1 0.159 larger*
PLRG1 0.168 smaller
SCFD1 0.189 smaller
AP1M1 0.196 smaller
RRP15 0.199 larger
U2AF1 0.199 smaller
RPS12 0.233 smaller
SNW1 0.253 larger
RPSA 0.272 smaller
ARCN1 0.289 smaller
SCD 0.289 larger
ATP5B 0.299 larger
RPS19 0.31 smaller
RPS16 0.313 smaller
DARS 0.314 smaller
RPL8 0.322 smaller
STX5 0.33 smaller
POLR2A 0.331 smaller
GSPT2 0.333 larger
EIF3G 0.334 larger
DNAJC3 0.343 smaller
PSMC5 0.346 smaller*
CPSF2 0.362 smaller
SEC23B 0.371 larger
RAB1A 0.382 smaller
SF3B1 0.421 smaller
PRKAR1A 0.435 smaller
RPS3 0.437 smaller
OGDHL 0.449 larger
SNRPD3 0.458 smaller
ACSF2 0.467 larger
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The details of the role for TRiC/CCT in AD are unknown;
however the finding that RNAi knockdown in the worm protects
against Ab-induced paralysis indicates that the chaperone in some
way mediates Ab toxicity. TRiC has been shown to remodel
oligomeric protein aggregates in a worm model of polyQ toxicity,
with a concomitant reduction in toxicity [35]. It is therefore
surprising that knock down TRiC components is protective in our
model of Ab toxicity, however there are a number of precedents
for a reduction of chaperone activity having a protective effect (see
[36–42]) and it is hypothesised that low levels of misfolded proteins
may induce, or help maintain, the activity of regenerative
pathways. Our additional finding that actin RNAi is also
protective in the worm screen may indicate that reducing the
levels of this important substrate for TRiC/CCT promotes the
ability of the chaperone to interact with STK24 and so promote
neuroregeneration.
Conclusions
In summary, the lack of a direct overlap between genes
implicated by the GWAS studies and the hits from our modifier
screen in C. elegans indicates that AD cannot simply be considered
synonymous with Ab toxicity. However using a +1 interactome
network approach we have shown that the experimental pattern of
overlap between worm and GWAS gene products was significantly
non-random. Of those worm genes that showed increased overlap
with GWAS lists, three are part of an abundant cytoplasmic
complex with important chaperone activity; the fourth gene coded
for b-actin that is an important substrate of the same chaperone.
The interaction that the TRiC/CCT chaperone has with tubulin,
STK24 and the MAPK pathway may explain how Ab promotes
tau-linked cytoplasmic pathology.
Methods
C. elegans strains
The C. elegans strain CL4176 [smg-1(cc546ts) dvIs27(pAF29
Pmyo-3::Ab42+pRF4)], expressing Ab in body-wall muscle, and
the non-Ab expressing control, CL802 [smg-1(cc546ts) rol-
6(su1006)] have been described previously [43]. The worms were
routinely cultured at the permissive temperature of 16uC on solid
peptone nematode growth media (NGM) as described previously
[44].
RNA interference (RNAi) treatment of C. elegans
Clones of HT115 E. coli carrying RNAi expression plasmids
from the whole-genome C. elegans feeding library (Geneservice,
UK) were cultured separately, in 500 ml LB medium containing
50 mg/ml ampicillin, overnight at 37uC. A control culture,
carrying empty plasmids without an RNAi insert, was grown
simultaneously under identical conditions. Bacteria were seeded
drop-wise onto solid NGM plates, supplemented with 25 mg/ml
carbencillin and 1 mM IPTG, and incubated overnight at room
temperature. Worm embryos were harvested from synchronised
worms as described previously [45] and transferred to NGM agar
plates seeded with RNAi-expressing, or control, bacteria and left
48 h to develop into L3 larvae. Ab expression was then induced by
increasing the ambient temperature to 23uC for 24 h, when the
worms were scored for the incidence of the paralysis phenotype.
Primary screen to detect RNAi modifiers of Ab-induced
paralysis
The interaction of each RNAi-expressing clone with the Ab
paralysis phenotype in the worm was assessed in triplicate and
compared with triplicate wells of worms fed with control bacteria
carrying an empty vector. Each plate also had a well containing
bacteria expressing RNAi to unc-22 that normally results in
uncoordinated body wall twitching. As a quality control, any plate
in which the unc-22 RNAi-fed worms failed to twitch was
discarded and the experiment was repeated.
Locomotor behaviour was assessed at two time-points following
the increase in ambient temperature. The first assay was
performed 22 h post-induction, at which time Ab-expressing
worms fed control bacterial cultures were all moving normally.
When all worms in each of the triplicate wells for a particular
RNAi clone at this time point were seen to be paralysed, then the
clone was defined as an enhancer of Ab toxicity. This enhance-
ment was specific to Ab-expressing worms as no similar paralysis
was seen in the corresponding treatment of non-Ab-expressing
CL802 worms. Clones that non-specifically paralyse worms were
not considered. The second time-point, at 32 hr, permitted the
detection of suppressors of the paralysis phenotype. At this time-
Table 4. Cont.
Gene p-value +1 interactome overlap [experimental vs MC]
NDUFA6 0.486 larger
UBA6 0.515 larger
CRNKL1 0.535 larger
MAT1A 0.539 smaller
RPL36AL 0.55 larger
ATP6V1A 0.557 larger
SERINC1 0.577 larger
EIF2B5 0.58 smaller
HIST1H2BA 0.58 smaller
AP1S2 0.655 smaller
ATP6V0C 0.759 larger
The human AD GWAS white+grey zone genes, and their +1 interactors, overlap with the human orthologues of worm-screen hits, and their +1 interactors. Worm screen
genes that have human orthologues with a significantly non-random +1 interactome overlap with the GWAS list are shown in bold. Worm screen genes that have
human orthologues that interact directly with GWAS genes are marked with an asterisk.
doi:10.1371/journal.pone.0102985.t004
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point, Ab-expressing worms under control conditions were all
paralysed and so any RNAi-expressing clone that protected the
locomotor function of all the worms, in triplicate wells, was defined
as a suppressor of Ab toxicity.
Secondary screen to confirm the RNAi modifiers of Ab-
induced paralysis
The secondary screen consisted of a further three experiments,
each performed in triplicate wells, for each hit from the primary
screen. Paralysis curves were generated by hourly observation of
locomotor behaviour and were analysed using Kaplan-Meier plots
with statistical significance being estimated using the Mantel-Cox
Log Rank test (GraphPad, Prism); p,0.05 was considered
significant.
Finding human orthologues of worm genes
According to our pre-planned study design, we considered only
those genes in C.elegans that have one or more human
orthologues. We used the EnsemblCompara phylogenetically
based orthology prediction method (http://www.ensembl.org/)
[17] to find human orthologues of worm genes with minimum
25% amino acid identity [46] with respect to the query gene
product. In cases where there was more than one human
orthologue, then the gene with the highest % identity was chosen.
In approximately 15% of cases one worm gene had multiple
human orthologues all with the same percent identity; in these
cases, the preferred orthologue was chosen using MetaPhOrs
(http://orthology.phylomedb.org/) [47] where the consistency
score for any orthology was used as the tie-breaker. This score is 1
where an orthology is supported by all the available databases and
decreases as agreement is less consistent.
Using this method, human orthologues for 61 out of 78 worm
genes were found. The human orthologues of this series of worm
genes was then compared with the GWAS white+grey zone genes
(Fig. S2.1) as published at the Database of Genotype and
Phenotype (dbGaP) of the National Center for Biotechnology
Information [48] (http://www.ncbi.nlm.nih.gov/projects/
gapplusprev/sgap_plus.htm, p,1025, Disease = ‘‘Alzheimer Dis-
ease’’, access date June 2013).
Network Generation
The ‘‘GWAS +1 interactome’’ consists of all the GWAS white+
grey zone genes plus all the genes encoding proteins with which
their products physically interact. The ‘‘worm +1 interactome’’
was generated in a similar manner, using 61 human orthologues of
the worm modifier screen ‘‘hits’’. The list of interactions was
retrieved from the ‘‘Biogrid’’ database (http://thebiogrid.org, v.
3.2.96) [19]. The statistical significance of the overlap between the
worm +1 interactome and the GWAS +1 interactome was
determined by Monte Carlo simulation [49].
Monte Carlo simulations
To test whether any particular worm screen hit g had a +1
interactome that overlapped more with the GWAS +1 interactome
than expected by chance, we used the following computational
algorithm (Fig. S2):
1. The size of the +1 interactome for each human orthologue of
the worm screen hits was determined.
2. Random +1 interactomes, of the same size as the network in
step 1, were then generated (Fig. S3). This was achieved by
randomly choosing one of the 7970 human orthologues of
worm genes, and then generating its +1 interactome and using
this list to progressively populate a random +1 interactome.
Once this random list had reached the required length, the
process was terminated. If, however, the first randomly selected
human orthologue of a worm gene had insufficient interactors
to completely populate the required random +1 interactome,
then additional random genes and their associated interactor
lists were added until the random list was complete.
3. The generated set of random genes was compared with the +1
interactome of the GWAS white+grey zone genes and the
number of identical genes was counted (the overlap).
4. Steps 2–3 were repeated 1000 times, yielding a Monte Carlo
set of 1000 overlap scores.
5. The number of times that the random overlap was equal to, or
greater, than the experimental overlap was counted - this was
termed nright,g (Fig. S4, panel A)
6. Similarly the number of times that the random overlap was
equal, or less, than the experimental score was also counted -
this was termed nleft,g (Fig. S4, panel B)
7. We divided either nright,g or nleft,g, whichever was smaller, by
the number of simulations (n = 1000) to give the p-value for the
overlap (Fig. S2), thus ensuring that a one-tailed test was
simulated.
Supporting Information
Figure S1 Paralysis timecourse following induction of
Ab expression. Increasing the ambient temperature to 23uC
when the worms are 48 h old (stage L3) induces Ab expression and
results in progressive paralysis in worms fed on E. coli containing
empty vector (a, round symbols). By contrast, a typical suppressor
clone rescues this locomotor deficit (square symbols). The
paralysed worms (b, arrows) are straighter and largely immobile
whereas non-paralysed worms exhibit a marked ‘‘roller’’ pheno-
type (c, arrowheads), but otherwise move normally.
(TIF)
Figure S2 Computational pipeline for determining the
significance of the overlap between the +1 interactomes
of worm-screen hits and GWAS white+grey zone genes.
The algorithm is described more fully in the ‘‘Monte Carlo
simulations’’ section of the methods section.
(TIF)
Figure S3 Generation of equivalent random +1 inter-
actomes. An illustration of how random +1 interactomes (right)
were generated to compare with the +1 interactomes of each of the
worm screen hits. Random +1 interactomes were generated
containing the same number of genes (in this example, n= 11).
Human orthologues of worm-screen hits are labeled with ‘‘1’’ (left).
Random human genes with a worm orthologue are labeled with
‘‘2’’ (right). Human +1 interactors are represented by small green
dots.
(TIF)
Figure S4 Estimating the significance of highly overlap-
ping/poorly overlapping +1 interactomes. The +1 inter-
actome of the human orthologues of worm screen genes may
overlap more than expected (panel A, contributing to nright) or less
than expected (panel B, contributing to nleft). Generation of 1000
random +1 interactomes allows the p value for the experimental +
1 interactome to be derived. Further details can be found in the
‘‘Monte Carlo simulations’’ section of the methods section.
(TIF)
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Figure S5 Venn diagram indicating the degree of the +1
interactome overlap for GWAS white+grey genes and
each of the significant genes from the worm screen.
Seven genes from the worm screen have human orthologues that
have +1 interactomes that overlap more or less than one would
expect by chance with the GWAS +1 interactome. Four overlap
more (left panel), and three less (right panel), than expected. The
area of each circle or overlap is proportional to the number of
genes. Worm screen genes that have human orthologues that
interact directly with GWAS white+grey zone gene products are
marked with asterisks.
(TIF)
Table S1 The 63 human genes in the AD GWAS white+grey
zones.
(DOCX)
Table S2 Worm RNAi modifiers for screens of various disease
models. The genes that modified fly phenotypes when targeted
with RNAi are listed for a) polyglutamine, b) tau and c) a-
synuclein.
(DOCX)
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